A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler((R)) to Budesonide/Formoterol Easyhaler((R)) (vol 36, pg 1756, 2019)

Syk, J; Vinge, I; Sorberg, M; Vahteristo, M; Rytila, P

Rytila, P (reprint author), Orion Corp, Orion Pharma, Espoo, Finland.

ADVANCES IN THERAPY, 2019; 36 (7): 1770

Abstract

Unfortunately, the mean difference in change from baseline ACT was incorrectly reported in the abstract as 19.0 vs. 20.8 instead of 18.9 vs. 20.7

Full Text Link